Putting public health needs at the centre of antibiotic drug development

GARDP develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. By focusing on both immediate and long-term solutions to AMR, we aim to create a new global antibiotic pipeline, an ecosystem for antibiotic R&D and access, that is driven by public health needs.
#Antibiotics #AMR #antibioticresistance #publichealth #nonprofit